Post Categories
Oligonucleotide Anti-Drug Antibodies (ADAs)
September 22, 2023
What is it? An anti-drug antibody, ADA, is an antibody that binds to the therapeutic drug. They are formed as an immune response when…
How Are Viruses Used in Gene Therapy?
September 20, 2023
Gene therapy has revolutionized the field of medical research by offering potential treatments for genetic disorders and diseases previously considered untreatable or incurable. A…
Going Non-Viral — Rethinking Gene Therapy Delivery
September 18, 2023
Gene therapies have ushered in a new era of medical possibilities, offering hope to patients with previously untreatable conditions. Their high costs, however, have…
Changing the Game for Obesity Treatment and Cardiovascular Care
September 11, 2023
Clinical trial data has demonstrated that the anti-obesity drug semaglutide, marketed for obesity and diabetes, could offer substantial protection against heart disease. The results…
In Vivo vs. Ex Vivo Gene Therapy
August 30, 2023
Ongoing developments in gene therapy continue to demonstrate its potential to transform the global healthcare system. Gene therapies may be the key to unlocking…
Growing Food in the Dark for Mars Missions and More
August 28, 2023
Every traveler knows that meal-planning is an important part of any long trip. As NASA gears up to send astronauts to Mars within the…
Understanding Therapeutic Oligonucleotides ADME
August 23, 2023
Therapeutic oligonucleotides are important for altering targeted RNA pathways through a variety of mechanisms, making them a versatile tool in drug development. Understanding their…
Vaccine-Derived Polio: A Persistent Threat Amid Eradication Progress
August 21, 2023
The global effort to eradicate wild poliovirus has made significant strides. Type 2 was declared eradicated in 2015 and type 3 in 2019. Only…
This Is Your Brain on Menopause — How Hormonal Changes Affect Brain Health
August 14, 2023
The interaction between menopause and the brain has long been underestimated, but recent research is shedding light on the neurological changes occurring during this…
For Babies Waiting for a Donor Heart, Could Xenotransplantation Extend Survival?
August 7, 2023
eGenesis, a biotech company in Cambridge, Massachusetts, is experimenting in the field of xenotransplantation by transplanting gene-edited pig hearts into infant baboons. The company’s…
Could the Next Blockbuster Drug be Designed by Artificial Intelligence?
July 31, 2023
Developing a new drug is a lengthy, difficult, and inefficient process. It is characterized by high costs and a substantial failure rate. Only one out…
Benefits of Gene Therapy
July 26, 2023
Gene therapy focuses on preventing or curing genetic conditions by manipulating the genetic material in living cells. For people with certain medical conditions, gene…
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…
